Header Logo

Connection

Jeffrey Hausdorff to Drug Resistance, Multiple

Back to Details
This is a "connection" page, showing publications Jeffrey Hausdorff has written about Drug Resistance, Multiple.
Jeffrey Hausdorff
Connection Strength
0.012
Drug Resistance, Multiple
  1. A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance. Clin Cancer Res. 2001 May; 7(5):1221-9.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.